Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
J Natl Cancer Inst (1993) 85(18):14928
Cancer Drug Resist
Cytosponge-trefoil factor 3 versus usual care to identify Barretts oesophagus in a primary care setting: a multicentre, pragmatic, randomised controlled trial
Research-use controls Purchasers confirm age, qualifications, facilities, and lawful in-vitro research use
Compliant Logistics Control: All orders are packed inside insulated, shock-absorbent containers to protect structural stability from transit hazards
Cancers 14 , 5225 (2022)
US$ 21.92
US$ 29.96
US$ 29.73
US$ 23.96
US$ 28.08
US$ 23.80
US$ 29.95
US$ 28.81
